US patent for cell therapy kit:
This article was originally published in Clinica
Executive Summary
Stem cell therapy pioneer Aastrom Biosciences has received a US patent covering its automated equipment for producing patient-specific cell therapy products. The Ann Arbor, Michigan-based company's AastromReplicell system, which is marketed in Europe but is not yet available in the US, is an instrumentation platform that can operate a family of patient-specific cell therapy kits.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.